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Abstract
Background: To evaluate the impact of osteoporosis on the patients' quality of life, particularly
in the absence of fractures.
Methods:  100 post-menopausal women (age 50-85) - 62 with uncomplicated  primary
osteoporosis and 38 with primary osteoporosis complicated by  vertebral fractures; all already
treated - were studied using two validated  questionnaires: Qualeffo-41 for quality of life in
osteoporosis, and Zung  for depression. Data were compared to those of 35 controls of
comparable  age, affected by a different chronic disease (hypothyroidism).
Results: Family history of osteoporosis and T-score of spine were similar  in the two subgroups
of osteoporotic women. Body mass index, age at  menopause and education level were similar in
the two subgroups of  osteoporotic women and in the control group.
The patients affected by osteoporosis perceived it as a disease affecting their personal life with
undesirable consequences: chronic pain (66% of women with fractures and 40% of women without
fractures), impaired physical ability, reduced social activity, poor well-being (21% of women without
fractures) and depressed mood (42% of women irrespective of fractures). Overall, 41% of the
women showed a reduced quality of life. On the contrary, in the control group only 11% reported
a reduced quality of life.
Conclusion: The quality of life of osteoporotic patients should be investigated even before
fractures, in order to develop appropriate counselling, support and care interventions to help
patients develop efficient strategies for accepting the disease and coping with it.
Background
Osteoporosis is a very common disease of bone, and fra-
gility fractures (i.e. fractures in the absence of relevant
trauma) are its typical complication and the most com-
mon presenting sign. For many years, the diagnosis of
osteoporosis was made only after the sudden occurrence
of a fragility fracture.
The most frequent sites of bone fragility fractures are wrist,
vertebrae, hip, ribs and humerus. While hip fractures have
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always been considered a cause of severe disability and
loss of independence [1,2], there is now increasing aware-
ness that all fractures substantially affect the patient's
quality of life [3-5].
With the availability of new techniques of bone densitom-
etry, and in particular of dual X-ray absorptiometry
(DXA), osteoporosis was defined as the loss of bone min-
eral beyond a certain threshold, even in the absence of
fractures. In 1994, the World Health Organization
(WHO) defined it as "a systemic skeletal disease character-
ized by a low bone mass and bone architectural derangements,
leading to an increased fracture risk" [6], and set the thresh-
old of bone loss for osteoporosis, at least for post-meno-
pausal women, at a T-score value of -2.5, as measured by
DXA.
The aim of this study was to evaluate the impact of oste-
oporosis per se – independently of fractures – on the
patients' quality of life; more specifically, to determine
whether, in normal clinical practice, the awareness of
being affected by osteoporosis has a special impact on the
patients' perceived quality of life.
Indeed, most studies have been focused on the impact of
fragility fractures. Our hypothesis, based on a very long
clinical experience, is that the sheer awareness of a
chronic, essentially progressive disease, with the well-
known risk of bone fractures in one's future, has a nega-
tive effect on the subjective perception of the quality of
life.
We thus involved a small control group of women of com-
parable age, affected by a different chronic disease
(hypothyroidism), to determine whether osteoporosis
could be considered to have a special impact on a patient's
perceived quality of life.
Methods
Patients
One hundred post-menopausal women, aged 66 ± 8.7
years (age range 50–85), affected by osteoporosis with or
without fractures, were enrolled consecutively at the out-
patient clinic of the Istituto Auxologico Italiano over a
period of about 4 months.
The diagnosis of osteoporosis was made on the basis of a
reduction in bone mineral density (BMD) at spine and
hip scan according to the WHO criteria, after a clinical and
biochemical exclusion of other causes of bone loss. Only
cases of primary osteoporosis were recruited. Secondary
osteoporoses were excluded in order to avoid the interfer-
ence of the primitive disease on the patient's quality of
life. In all cases, osteoporosis was diagnosed before the
present study, and all patients were receiving a specific
treatment. 13 of the patients (13%) (9 in group A, without
fractures; 4 in group B, with fractures) had used hormonal
replacement therapy (HRT), starting at menopause and
continuing for 3 to 6 years. No patients were on HRT at
the time of the study. All the patients had had regular eval-
uation of 25-OH vitamin D serum levels also before the
study, and they took vitamin D supplements if needed.
25-OH vitamin D levels were steadily normal (over 30 ng/
Table 1: Main characteristics of patients and controls
controls OP without fractures OP with fractures
number of women 35 62 38
age (years) 58.9 ± 7.9 64.5 ± 8.4 70.3 ± 7.8 *
BMI (kg/m2) 27.6 ± 3.4 25.6 ± 3.1 25.1 ± 2.9
age at menopause (years) 51.4 ± 2.9 51.9 ± 3.4 52 ± 3.8
BMD T-score
lumbar spine -1.3 ± .3 § -3.2 ± .8 -3.3 ± 1
Femur -1.1 ± .5 § -2.6 ± .8 -3.1 ± 1.2°
education (years of school)
<= 8 31% (11 women) 34.4% (21 women) 35.9% (14 women)
9–13 54.3% (19 women) 49.2% (30 women) 51.3% (20 women)
>13 14.2% (5 women) 16.4% (10 women) 12.8% (5 women)
Family history of OP 8.5% (3 women)ˆ 27.8% (17 women) 28.2% (11 women)
Data are expressed as mean ± SD and as percentages.
Student's t test for unpaired data or chi-square of Fischer's exact test.
OP = osteoporosis
* p < 0.05 versus controls and versus OP without fractures
° p < 0.05 versus OP without fractures
§ p < 0.02 versus OP without fractures and versus OP with fractures
ˆ p < 0.03 versus OP without fractures and versus OP with fracturesHealth and Quality of Life Outcomes 2005, 3:78 http://www.hqlo.com/content/3/1/78
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ml) in all patients before and during the study. All the
patients were living at home alone or with relatives, did
not require personal assistance and were independent
enough to come to the hospital's outpatient clinic.
The inclusion criteria included being able to autono-
mously read, understand and answer the simple questions
asked in the questionnaires used in the study.
Beyond secondary osteoporosis, the exclusion criteria
were the presence of other diseases affecting quality of life
(e.g. cancer, moderate to severe chronic renal insuffi-
ciency, chronic respiratory diseases, cardiovascular dis-
eases including uncontrolled hypertension, diabetes) and
the presence of severe cognitive, visual or hearing impair-
ments.
All the fractures were clinically symptomatic, and due to
bone fragility and not to major trauma. For patients with
a history of fractures, the last fracture must have occurred
at least 6 months before the study, in order to evaluate
only the impact of an established condition and not that
of an acute phase.
Control group
A control group of 35 women, affected by a different
chronic disease (hypothyroidism, stable for at least 3
years) selected among the outpatients of the same Insti-
tute, was also involved and filled out the questionnaires.
They were in the same age range of the patients, but with-
out osteoporosis (mean BMD T-score -1.3 ± .3), back pain
or fractures. Also these patients were aware of their dis-
ease, and were under treatment (levothyroxine replace-
ment therapy). The inclusion and exclusion criteria were
the same as for osteoporotic patients, apart bone loss.
Methods
Bone mineral density was measured by DXA (Hologic
QDR 2000) at lumbar spine and proximal hip. All verte-
bral fractures were confirmed by X-rays. All women under-
went a lateral X-ray exam of the dorsal and lumbar spine
at study entry: vertebral deformity was defined according
to Genant's criteria [7].
The perceived quality of life was assessed by two standard-
ized, internationally and nationally validated question-
naires: Qualeffo-41 for quality of life in osteoporosis, and
Zung for depression.
Qualeffo-41 has five domains: pain, physical function,
social function, general health perception, mental func-
tion (mood) [8,9].
The Zung Depression Scale is a self-report scale consisting
of 20 items, each with a four-point severity rating [10].
The scale has often been used in the assessment of mood
in people of mixed ages, and it has been validated in many
studies [11-13]. When a score of 50 is used as the cut-off
point, it is sensitive in detecting depression in epidemio-
logical studies of persons over fifty years of age.
The patients and the controls were given the question-
naires during a routine follow-up evaluation, and filled
them out on the premises at the Istituto Auxologico Ital-
iano. All the patients had an interview with a psycholo-
gist, to exclude the presence of affective disorders that
could influence the results of the tests.
The study protocol was approved by the Ethical Commit-
tee of the Istituto Auxologico Italiano.
Statistics
All the questionnaires were answered completely and
were analyzed according to the published scoring algo-
rithm. Statistical analysis was performed using the SPSS
statistical package 11.0 for Windows (SPSS Inc., Chicago,
IL, USA). Data are expressed as mean ± SD or percentage.
Student's t test for unpaired data, or the non parametric
Mann-Whitney test and the chi-square, or the Fisher's
exact test, as appropriate, were used to compare data
between the two osteoporosis groups (with or without
fractures) and the control group. Anova was also used to
Table 2: Scores of Zung test
Controls OP without 
fractures
OP with vertebral 
fractures
p-value
ANOVA OP w/out Fx vs. OP w/ Fx* OP w/out Fx vs. controls* OP w/ Fx vs. controls*
39.9 ± 10 48.6 ± 9 52.3 ± 12 <0.051 NS NS <0.05
correlation between BMD T-score and Zung Coefficient -0.18 p-value = NS
Data are expressed as mean ± SD
OP w/out Fx = osteoporosis without fractures
OP w/ Fx = osteoporosis with vertebral fractures
* Mann-Whitney testHealth and Quality of Life Outcomes 2005, 3:78 http://www.hqlo.com/content/3/1/78
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compare data among groups. Significance of multiple
comparisons were adjusted by the Bonferroni's correction.
Association between BMD, expressed as absolute value or
T-score, and questionnaires' scores were evaluated by
Pearson correlation coefficient in the patients affected by
osteoporosis. Correlations were further adjusted for age
and social status. A p value < 0.05 was considered to indi-
cate statistical significance (two-tailed tests).
No significant differences were observed between the
women who had used HRT (13 out of 100) and those who
did not.
Results
The main characteristics of the patients and the controls
are summarized in Table 1. The patients were divided in
two groups: Group A: 62 women with uncomplicated oste-
oporosis, defined as a T-score <-2.5 according to the WHO
criteria; Group B: 38 women with osteoporosis, defined as
above, but complicated by vertebral fractures. All 38
women had had at least 1 vertebral fracture, but none had
had hip or other peripheral fractures.
The control group and the two groups of women affected
by osteoporosis were not significantly different. Body
mass index (BMI), age at menopause, education level
(evaluated as the number of school years), family history
of osteoporosis were considered (Table 1). Of course,
bone density in the control group was in the normal
range. The T-score of spine was similar in the two groups
of women with osteoporosis. The only differences were
the mean age and the T-score values at hip, which were
respectively a little higher and a little lower in the group
with fractures (Table 1)
The evaluation of the Zung questionnaire revealed that
some of the women affected by osteoporosis suffered
symptoms of depression (40% of the women), but
nobody reached the score of clinical depression from a
psycho-pathological point of view. In the control group, a
lower number of women had symptoms of depression
(23% of the women) (Table 2).
No significant correlation was found between the Zung
questionnaire score and the BMD value, expressed as
either the absolute value or the T-score (Table 2). 42% of
women with osteoporosis had symptoms of depression
according to the "mental function" domain of Qualeffo-
41 [8,9], a result in accordance with the Zung test.
In the osteoporotic patients considered globally, the cor-
relation between the BMD T-score value and the Qualeffo-
41 score, adjusted for age, social status (e.g. education,
marriage, living alone or not, etc.) and lifestyle habits (e.g.
smoking, drinking), was significant (p < 0.001), inde-
pendently from the presence of fractures. Three domains
were particularly significant: physical function (p < 0.01),
social function (p < 0.001), general health perception (p
< 0.01) (Table 3).
Pain was present in 50% of cases, independently from age,
and in 26% for more than 10 hours a day. 25 women out
of 38 with fractures (66%) and 25 out of 62 without frac-
tures (40%) reported pain. The presence of vertebral frac-
tures increased the score of the "pain" domain (Table 4).
The Qualeffo score of pain was significantly higher in
both groups of patients with osteoporosis with respect to
the control group. In this latter group pain was present
only in 2 cases (5,7%).
In the domain of physical function, 46% of the women
under 65 years of age indicated the perception of a signif-
icant physical change, as did 65% of those over 65. The
presence of fractures increased the perception of physical
change (Table 4). The comparison with the control group
revealed a slight difference with Group A, and a significant
difference with Group B (Table 4).
In the domain of general health perception, 58% of the
women had a sense of poor well-being. 13 women with-
Table 3: Correlation between BMD T-score and domains of Qualeffo-41 in 100 osteoporotic women
QUALEFFO-41 domain
pain physical 
function
social function health 
perception
mental function global score
Crude correlation
Coefficient -0.08 -0.32 -0.35 -0.27 -0.13 -0.29
p-value NS <0.01 <0.001 <0.01 NS <0.01
Correlation adjusted for 
age and social status
Coefficient -0.12 -0.24 -0.32 -0.23 -0.12 -0.26
p-value NS <0.02 <0.001 <0.01 NS <0.01Health and Quality of Life Outcomes 2005, 3:78 http://www.hqlo.com/content/3/1/78
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out fractures (21%) out of 62 reported a reduction of their
health perception (Table 4). Comparing their present
level of well-being with that of 10 years before, 58% of the
women aged less than 65 indicated a deterioration, as did
83% of those aged 65 or more. These percentages were not
significantly changed by the presence of fractures. In the
control group, only 3 women (8,6%), aged 65 to 68 years,
reported a reduction of their health perception (Table 4).
Overall, 41% of the women affected by osteoporosis had
a reduced quality of life: 32% (23 cases) of the women
with uncomplicated osteoporosis and 55% (21 cases) of
the women with osteoporosis complicated by fractures.
On the contrary, a reduction of quality of life was present
in only 11,4% of the controls.
Discussion
In an editorial published twelve years ago, Kanis et al
already recognized the need "to rethink vertebral oste-
oporosis and to focus more closely than hitherto on the
quality of life of these patients" [14]. However, only in
these last years some information on the quality of life of
osteoporotic patients has been gathered, generally after
fractures [15-19].
Most information has been collected thanks to the efforts
of some researchers to develop specific instruments to test
the physical and emotional disability generated by the
disease. Generic instruments available for measuring
quality of life (such as SF-36) are useful to evaluate health
in general but they lack disease specificity [20-22]. More
recently, some specific instruments were developed to
give a more accurate measure of the quality of life in oste-
oporosis. One of the first was Qualeffo-41, which has
been translated and validated in different languages
including Italian [8,9]. This questionnaire has proven to
be repeatable, coherent, and able to discriminate between
patients and controls. In the last years other specific ques-
tionnaires have been developed, but not all were as exten-
sively used and validated in different countries as
Qualeffo-41 [23-26]. This is the reason why we decided to
use the Qualeffo-41 questionnaire.
While most previous studies included only women with
osteoporosis complicated by fractures, we chose to
include also a group of patients with a diagnosis of oste-
oporosis but without fractures, a condition which is usu-
ally considered asymptomatic. And we included also a
control group of women of comparable age, affected by a
different chronic disease of comparable severity and
essentially asymptomatic (hypothyroidism), who were
also on a long term therapy and in a stable clinical condi-
tion.
In previous studies, it was demonstrated that vertebral
fractures are associated with reduced quality of life and
that physical function and emotional status are negatively
affected [27,28]. The use of specific questionnaires
showed that the reduction of quality of life depends on
the number of vertebral fractures and on their location
within the spine, with significantly different scores
[28,29].
In our study we did not try to evaluate this particular
aspect, given the relatively small sample, but we consid-
ered the vertebral fractures as a whole, without consider-
ing the number of vertebral fractures and their location.
To the specific test measuring the perceived quality of life
(Qualeffo) in osteoporosis, we also added the Zung
Depression Scale to measure depression. An essential pre-
requisite for the correct interpretation of the results is to
be able to discriminate between a condition of reactive
depression, such as is frequently encountered in chroni-
cally ill subjects, and that of endogenous depression (mel-
ancholia). Both the Zung questionnaire and the related
domain of Qualeffo-41 showed that a depressed mood
was present in about 40% of our patients, independently
Table 4: Scores in five Qualeffo-41 domains
Qualeffo-41 
domain
Controls OP w/out 
fractures
OP w/ 
fractures
p-value
ANOVA OP w/out Fx vs OP w/ Fx * OP w/out Fx vs controls* OP w/ Fx vs controls*
Pain 18 ± 4.5 40.7 ± 18.5 47.4 ± 20.5 <0.001 NS <0.005 <0.005
Physical function 16.9 ± 3.4 21.6 ± 16.3 40.5 ± 20.6 <0.001 <0.0001 NS <0.001
Social function 26.2 ± 9.3 36.2 ± 24.6 52.6 ± 27.3 <0.05 <0.005 NS <0.002
Health perception 34.4 ± 12 58.5 ± 19.6 70.9 ± 22.1 <0.05 <0.004 <0.05 <0.0001
Mental function 35.9± 10.2 40.7 ± 18.5 47.4 ± 20.5 NS NS NS NS
Global score 25.6 ± 8.9 39.5 ± 14.5 51.7 ± 18.7 <0.02 <0.001 <0.05 <0.001
Data are expressed as mean ± SD
OP w/out Fx = osteoporosis without fractures
OP w/ Fx = osteoporosis with vertebral fractures
* Mann-Whitney testHealth and Quality of Life Outcomes 2005, 3:78 http://www.hqlo.com/content/3/1/78
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of fractures, while nobody had a major depressive disor-
der as defined by the DSM-IV [30], considering both their
past and their recent history.
In accordance with the study of Oleksik et al. [29], the
mental function of our patients was not influenced by the
presence of the disease, whether they had suffered frac-
tures or not. This is an important aspect, as it strongly sup-
ports the hypothesis that the physical constraints of the
disease and not the mental impairment cause the reduc-
tion in physical abilities, the consequent reduction in
social activities and in autonomy, the permanent modifi-
cation of body image, and the perception of general
health. Moreover, the comparison with a control group of
women affected by another chronic disease confirmed the
lack of mental function involvement.
Another extremely important aspect evidenced by our
study was the presence of pain in a significant number of
patients before the occurrence of vertebral fractures (clin-
ical or even morphometric). Osteoporosis is generally
considered a silent disease before the occurrence of frac-
tures, but we found that pain was often present in the
group of women without known fractures (a clear differ-
ence with respect to the control group). Chronic pain in
osteoporosis is poorly considered even in the presence of
vertebral fractures [31-33], and it is obviously even more
underestimated without them. There is now ample con-
sensus that undertreated chronic pain may become "a dis-
ease within the disease" and is often a cause of subclinical
or clinical depression [34,35]. Our study demonstrates
that physicians dealing with osteoporotic patients must
pay serious attention to the problem of chronic pain, and
even in the absence of fractures.
Recently, Dhillon et al. demonstrated that women with
osteoporosis have a reduced health-related quality of life,
independently of prior fractures [36]. In our study, the use
of a test (Qualeffo), specifically designed for osteoporosis
demonstrated even better the effect of the disease itself,
without the presence of its main complication (fragility
fractures). We think that our results are even more rele-
vant because of the comparison with a control group
affected by a different chronic disease.
A reduced quality of life was present in our patients not-
withstanding their stable, non-alarming condition, with
the diagnosis of osteoporosis back in the past. All of them
were following a standard therapy for osteoporosis, well
known to be effective in the majority of cases. The pres-
ence of a therapy is considered a factor which influences
positively a patient's quality of life [37,38], but notwith-
standing this, in our patients, the therapy for osteoporosis
was not able to completely eliminate the impact of the
disease on the perceived quality of life.
Conclusion
Any chronic disease can induce a negative perception of
one's quality of life, especially considering the future and
the risk of losing independence or suffering pain. We
aimed at determining whether osteoporosis, a very com-
mon disease, could have a special impact on a patient's
perceived quality of life.
The results of the Qualeffo and Zung tests revealed signif-
icant differences between the osteoporosis patients and
the control group. Patients with osteoporosis, even in the
absence of fractures, had a more depressed mood and a
lower quality of life.
Osteoporosis was perceived by our patients as a disease
leading to severe discomfort and/or disability, and affect-
ing different aspects of personal life with a variety of unde-
sirable consequences, such as chronic pain, reduced
physical ability, reduced social activity, poor well-being,
and depressed mood. The fear of losing autonomy and
independence was extremely high.
On the basis of our results in a relatively small sample
(100 patients), we think that the quality of life of oste-
oporotic patients should be thoroughly investigated even
before the occurrence of fractures, in order to develop the
appropriate intervention (e.g. counseling, support and
care) in all the different phases of the disease. This will
help patients to develop more efficient strategies for
accepting the disease and coping with it. The information
obtained through the use of appropriate questionnaires
could be a powerful instrument for the physician or car-
egiver in the global management of osteoporosis.
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